Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

143
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
143
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

178
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
178
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

432
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
432

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Arrests During Inpatient Gastrointestinal Endoscopic Procedures: A United States Nationwide Assessment.

Digestive diseases and sciences·2026
Same author

Financial burden among liver transplant candidates is associated with financial distress and work impairment: A U.S. multicenter study.

Hepatology communications·2026
Same author

ABO Incompatible Deceased Donor Liver Transplants in Infants (Age < 1 Year): A Single-Center Experience.

Pediatric transplantation·2026
Same author

Changes in Inpatient Coding for Hepatic Encephalopathy After Introduction of ICD-10 Code K76.82.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Sociodemographic disparities in documented nonadherence to medication for hepatic encephalopathy: a National Inpatient Sample analysis.

Annals of gastroenterology·2026
Same author

Hypoglycemia Occurrence and Risk Factors in Insulin Independent Patients After Total Pancreatectomy With Islet Autotransplantation.

Clinical transplantation·2026

Related Experiment Video

Updated: Jan 2, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure

Published on: August 14, 2017

15.3K

Changes in liver allocation in United States.

Thomas M Leventhal1, Ellen Florek2, Srinath Chinnakotla2

  • 1Department of Medicine.

Current Opinion in Organ Transplantation
|December 14, 2019
PubMed
Summary
This summary is machine-generated.

The United States has updated its liver allocation system to improve fairness and reduce waitlist deaths. Recent policy changes aim for broader organ sharing, with outcomes eagerly anticipated.

More Related Videos

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.9K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

1.2K

Related Experiment Videos

Last Updated: Jan 2, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure

Published on: August 14, 2017

15.3K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.9K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

1.2K

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Public Health Policy

Background:

  • Liver transplantation success has increased demand for organs, creating a disparity between patient need and donor availability.
  • Prioritization systems are essential for managing organ allocation and improving outcomes for end-stage liver disease patients.
  • The liver allocation system has undergone continuous evolution since its inception.

Purpose of the Study:

  • To review significant changes in liver allocation policies in the United States.
  • To analyze the evolution of liver allocation systems, including the MELD score and recent policy adjustments.
  • To focus on the impact of recent policy shifts on liver transplantation practices.

Main Methods:

  • Review of historical liver allocation policies in the US.
  • Analysis of the implementation and impact of the Model for End-Stage Liver Disease (MELD) system.
  • Examination of recent United Network for Organ Sharing (UNOS) policy changes eliminating donor service areas (DSAs) and regions.

Main Results:

  • The liver allocation system has evolved significantly, with the MELD system introduced in 2002.
  • Recent policy changes by UNOS aim to broaden liver sharing and align with federal regulations.
  • The new policy, which removes DSAs and regions, is awaiting implementation.

Conclusions:

  • An ideal liver allocation policy should be fair, equitable, reduce waitlist mortality, and improve post-transplant outcomes.
  • The full impact of the latest liver allocation policy changes on transplantation in the US is yet to be determined.
  • Ongoing evaluation is crucial to assess the effectiveness of evolving liver allocation strategies.